Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3A | P49840 | 15/20 | 0.78 |
| ▸ | GSK3B | P49841 | 15/20 | 0.78 |
| ▸ | CDK5 | Q00535 | 14/20 | 0.78 |
| ▸ | CDK5R1 | Q15078 | 14/20 | 0.78 |
| ▸ | CDK1 | P06493 | 13/20 | 0.78 |
| ▸ | CCNB1 | P14635 | 13/20 | 0.78 |
| ▸ | CCNB2 | O95067 | 12/20 | 0.78 |
| ▸ | CCNB3 | Q8WWL7 | 12/20 | 0.78 |
| ▸ | AURKA | O14965 | 2/20 | 0.74 |
| ▸ | AURKB | Q96GD4 | 2/20 | 0.74 |
| ▸ | AURKC | Q9UQB9 | 2/20 | 0.74 |
| ▸ | AHR | P35869 | 1/20 | 0.56 |
| ▸ | JAK2 | O60674 | 1/20 | 0.55 |
| ▸ | LYN | P07948 | 1/20 | 0.55 |
| ▸ | HCK | P08631 | 1/20 | 0.55 |
| ▸ | SRC | P12931 | 1/20 | 0.55 |
| ▸ | JAK1 | P23458 | 1/20 | 0.55 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.55 |
| ▸ | CDK2 | P24941 | 1/20 | 0.55 |
| ▸ | TYK2 | P29597 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30597656 | 0.85 | GSK3B (1.00) | GSK3AGSK3BCDK5CDK5R1CDK1 | |
| SCHEMBL30319832 | 0.84 | CDK1 (1.00) | GSK3AGSK3BCDK5CDK5R1CDK1 | |
| SCHEMBL30597678 | 0.76 | GSK3A (1.00) | GSK3AGSK3BCDK5CDK5R1CDK1 | |
| SCHEMBL31060593 | 0.72 | GSK3B (1.00) | GSK3AGSK3BCDK5CDK5R1CDK1 | |
| SCHEMBL30319811 | 0.72 | GSK3B (1.00) | GSK3AGSK3BCDK5CDK5R1CDK1 | |
| SCHEMBL29359170 | 0.72 | CDK1 (1.00) | GSK3AGSK3BCDK5CDK5R1CDK1 | |
| SCHEMBL29447183 | 0.72 | CDK1 (1.00) | GSK3AGSK3BCDK5CDK5R1CDK1 | |
| SCHEMBL30094663 | 0.67 | GSK3A (1.00) | GSK3AGSK3BCDK5CDK5R1CDK1 | |
| SCHEMBL29961097 | 0.67 | GSK3A (1.00) | GSK3AGSK3BCDK5CDK5R1CDK1 | |
| SCHEMBL31061457 | 0.65 | GSK3A (1.00) | GSK3AGSK3BCDK5CDK5R1CDK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260125650-A1 | METHODS AND COMPOSITIONS FOR GENERATING HEPATOCYTES | TRAILHEAD BIOSYSTEMS INC (US) | 2026-05-07 | — | — | US | claimed |
| EP-4728051-A1 | STANDARDISING PLURIPOTENT STEM CELLS | United Kingdom Research and Innovation (GB) | 2026-04-22 | — | — | EP | claimed |
| US-20260015632-A1 | CULTURE MEDIUM COMBINATION FOR INDUCING DIFFERENTIATION OF PLURIPOTENT STEM CELLS INTO CD34+ HEMATOPOIETIC STEM/PROGENITOR CELLS | SHENZHEN CELL INSPIRE BIOTECHNOLOGY CO., LTD. (CN) | 2026-01-15 | — | — | US | claimed |
| EP-4615506-A1 | USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES | Sahin, Fikret (TR) | 2025-09-17 | — | — | EP | claimed |
| US-20250268948-A1 | COMPOSITIONS AND METHODS FOR TREATING POST ACUTE SEQUELAE OF SARS-COV-2 INFECTION (LONG COVID) | AE CAPITAL LIMITED (VG) | 2025-08-28 | — | — | US | claimed |
| US-20250205286-A1 | COMPOSITIONS, REAGENTS, AND METHODS FOR TREATING PITT-HOPKINS SYNDROME | AE CAPITAL LIMITED (VG) | 2025-06-26 | — | — | US | claimed |
| CN-118272305-B | Immune cell culture medium and application thereof | 深圳泽医细胞治疗集团有限公司 | 2025-04-08 | — | — | CN | claimed |
| WO-2024256607-A1 | STANDARDISING PLURIPOTENT STEM CELLS | UNITED KINGDOM RESEARCH AND INNOVATION (GB) | 2024-12-19 | — | — | WO | claimed |
| WO-2024258363-A1 | USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES | SAHIN FIKRET (TR) | 2024-12-19 | — | — | WO | claimed |
| US-20240360415-A1 | MUSCLE CELLS DIFFERENTIATED FROM PLURIPOTENT CELLS, METHODS OF PRODUCING SAME AND USE THEREOF | ALEPH FARMS LTD. (IL) | 2024-10-31 | — | — | US | claimed |
| CN-117802034-A | Method for spontaneous assembly of pluripotent stem cells into blastocysts and application thereof | 广州国家实验室 | 2024-04-02 | — | — | CN | claimed |
| CN-117795059-A | Muscle cells differentiated from pluripotent cells, methods of production and uses thereof | 阿利夫农场公司 | 2024-03-29 | — | — | CN | claimed |
| CN-114540278-B | Microvascular in-vitro culture method and culture solution | 青岛大学 | 2023-11-21 | — | — | CN | claimed |
| WO-2023200882-A1 | COMPOSITIONS AND METHODS FOR TREATING POST ACUTE SEQUELAE OF SARS-COV-2 INFECTION (LONG COVID) | Vitro Biopharma, Inc. (US) | 2023-10-19 | — | — | WO | claimed |
| WO-2023183656-A1 | COMPOSITIONS, REAGENTS, AND METHODS FOR TREATING PITT-HOPKINS SYNDROME | Vitro Biopharma, Inc. (US) | 2023-09-28 | — | — | WO | claimed |
| CN-115975908-A | Endometrioid organ model and construction method and application thereof | 北京大学第三医院（北京大学第三临床医学院） | 2023-04-18 | — | — | CN | claimed |
| CN-114874973-B | Culture medium and culture method for obtaining mature hepatocytes | 深圳市三启生物技术有限公司 | 2023-03-21 | — | — | CN | claimed |
| WO-2023017509-A1 | MUSCLE CELLS DIFFERENTIATED FROM PLURIPOTENT CELLS, METHODS OF PRODUCING SAME AND USE THEREOF | ALEPH FARMS LTD. (IL) | 2023-02-16 | — | — | WO | claimed |
| CN-114874973-A | Culture medium and culture method for obtaining mature hepatocytes | 深圳市三启生物技术有限公司 | 2022-08-09 | — | — | CN | claimed |
| CN-114540278-A | Microvessel in-vitro culture method and culture solution | 青岛大学 | 2022-05-27 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260015632-A1 | CULTURE MEDIUM COMBINATION FOR INDUCING DIFFERENTIATION OF PLURIPOTENT STEM CELLS INTO CD34+ HEMATOPOIETIC STEM/PROGENITOR CELLS | KIT, JAK1, HGF | GSK3A 141/4885GSK3B 94/4885CDK5 2044/4885 |
| US-20260125650-A1 | METHODS AND COMPOSITIONS FOR GENERATING HEPATOCYTES | WNT3A, GSK3B, GSK3A | GSK3A 3/4885GSK3B 2/4885CDK5 919/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.